Phenotypic characterization of juvenile idiopathic arthritis in African American children

Journal of Rheumatology

Volumn 43, Issue 4, 2016, Pages 799-803

  Fitzpatrick, Lauren ^a   Broadaway, K Alaine ^e   Ponder, Lori ^b   Angeles Han, Sheila T ^e   Jenkins, Kirsten ^c   Rouster Stevens, Kelly ^e   Pelajo, Christina F ^c   Conneely, Karen ^e   Epstein, Michael P ^e   Lopez Benitez, Jorge ^d   Vogler, Larry B ^e   Prahalad, Sampath ^e  

^a GREATER BALTIMORE MEDICAL CENTER   (United States)

^b Children's Healthcare of Atlanta   (Canada)

^c Pequeno Principe Hospital   (Brazil)

^d TUFTS MEDICAL CENTER   (United States)

^e CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

African American; Juvenile idiopathic arthritis; Phenotype; Registries

Indexed keywords

ANTINUCLEAR ANTIBODY; BIOLOGICAL PRODUCT; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR; STEROID; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; ETHNIC DIFFERENCE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPIC VARIATION; POLYARTHRITIS; PRIORITY JOURNAL; UNITED STATES; ARTHRITIS, JUVENILE; BLOOD; IMMUNOLOGY; PHENOTYPE; PRESCHOOL CHILD; REGISTER; SYMPTOM ASSESSMENT;

AFRICAN AMERICANS; ARTHRITIS, JUVENILE; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PEPTIDES, CYCLIC; PHENOTYPE; REGISTRIES; RHEUMATOID FACTOR; SYMPTOM ASSESSMENT;

EID: 84982135149     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.150891     Document Type: Article

References (15)

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
2. Kunjir V, Venugopalan A, Chopra A. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: A community-based cohort study. J Rheumatol 2010;37:1756-62.
3. Yilmaz M, Kendirli SG, Altintas DU, Karakoc GB, Inal A, Kilic M. Juvenile idiopathic arthritis profile in Turkish children. Pediatr Int 2008;50:154-8.
4. Weakley K, Esser M, Scott C. Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa. Pediatr Rheumatol Online J 2012;10:35.
5. Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: Ethnicity as a risk factor. Arthritis Rheum 2007;56:1974-84.
6. Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol 1997;24:1826-9.
7. Ringold S, Beukelman T, Nigrovic PA, Kimura Y; CARRA Registry Site Principal Investigators. Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: A cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. J Rheumatol 2013;40:936-42.
8. Prahalad S, Glass DN. A comprehensive review of the genetics of juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2008;6:11.
9. Hinks A, Cobb J, Marion MC, Prahalad S, Sudman M, Bowes J, et al; Boston Children's JIA Registry; British Society of Paediatric and Adolescent Rheumatology (BSPAR) Study Group; Childhood Arthritis Prospective Study (CAPS); Childhood Arthritis Response to Medication Study (CHARMS); German Society for Pediatric Rheumatology (GKJR); JIA Gene Expression Study; NIAMS JIA Genetic Registry; TREAT Study; United Kingdom Juvenile Idiopathic Arthritis Genetics Consortium (UKJIAGC). Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 2013;45:664-9.
10. Pelajo CF, Angeles-Han ST, Prahalad S, Sgarlat CM, Davis TE, Miller LC, et al. Evaluation of the association between Hispanic ethnicity and disease activity and severity in a large cohort of patients with juvenile idiopathic arthritis. Rheumatol Int 2013;33:2549-54.
11. Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 2011;63:267-75.
12. Saurenmann RK, Levin AV, Feldman BM, Laxer RM, Schneider R, Silverman ED. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum 2010;62:1824-8.
13. Angeles-Han ST, Pelajo CF, Vogler LB, Rouster-Stevens K, Kennedy C, Ponder L, et al; CARRA Registry Investigators. Risk Markers of Juvenile Idiopathic Arthritis-associated Uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. J Rheumatol 2013;40:2088-96.
14. White JM, O'Connor S, Winter HS, Heyman MB, Kirschner BS, Ferry GD, et al. Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol 2008;6:1361-9.
15. Gutiérrez-Suárez R, Pistorio A, Cespedes Cruz A, Norambuena X, Flato B, Rumba I, et al; Pediatric Rheumatology International Trials Organisation (PRINTO). Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology 2007;46:314-20.